This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignee: New York University. Active years: 1995-2016.
Company Filing History:
Years Active: 1995-2016
Title: The Innovations of Edward Y. Skolnik
Introduction
Edward Y. Skolnik is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of polycystic kidney disease. With a total of 7 patents to his name, Skolnik's work has the potential to impact many lives.
Latest Patents
Skolnik's latest patents include innovative methods for treating autosomal dominant polycystic kidney disease (ADPKD). These methods focus on administering glutaminase1 inhibitors to subjects afflicted with ADPKD. The patents encompass the use and application of compounds or agents that inhibit glutaminase1 for treating this condition. Another notable patent involves an expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases. This invention relates to a novel method for identifying target proteins that can bind to and/or serve as substrates for receptor or cytoplasmic tyrosine kinases.
Career Highlights
Edward Y. Skolnik is affiliated with New York University, where he conducts his research and develops his inventions. His work has garnered attention in the scientific community, contributing to advancements in medical treatments.
Collaborations
Skolnik has collaborated with notable colleagues such as Joseph Schlessinger and Benjamin L. Margolis. These partnerships have further enriched his research and innovation efforts.
Conclusion
Edward Y. Skolnik's contributions to medical research through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in the treatment of complex diseases.